Highlights on MFS analysis from combined treatments in high-risk advanced prostate cancer
ESMO 2021: STAMPEDE Prostate Cancer Trial
Share.
About Author
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
